Cure Sickle Cell
$9,872,158OT3FY2020HLNIH
Medical College Of Wisconsin, Milwaukee WI
Investigators
Linked publications & trials
Paper 38746109Paper 38635762Paper 36881031Paper 36623245Paper 36477467Paper 35302009Paper 34781066Paper 34584240Paper 34452722Paper 34374445Paper 34224915Paper 33785862Paper 33245834
Abstract
The Cure Sickle Cell (CureSC) Initiative was created in 2017 by the National Heart, Lung, and Blood Institute (NIH/NHLBI) to: ? Actively engage the sickle cell disease community of patients, family members, caregivers and advocates to work together on a path to the cure ? Utilize the emergence of safe reliable genetic therapies that broadens opportunities to improve the lives of individuals with sickle cell disease ? Use public-private partnership and collaboration among government agencies, biopharmaceutical companies and researchers to result in more rapid advancement of new and innovative treatments and technologies
View original record on NIH RePORTER →